Show simple item record

dc.contributor.authorGonzalez Malagon, SG
dc.contributor.authorLopez Muñoz, AM
dc.contributor.authorDoro, D
dc.contributor.authorBolger, TG
dc.contributor.authorPoon, E
dc.contributor.authorTucker, ER
dc.contributor.authorAdel Al-Lami, H
dc.contributor.authorKrause, M
dc.contributor.authorPhiel, CJ
dc.contributor.authorChesler, L
dc.contributor.authorLiu, KJ
dc.date.accessioned2018-03-16T10:01:25Z
dc.date.issued2018-03-19
dc.identifier.citationNature communications, 2018, 9 (1), pp. 1126 - ?
dc.identifier.issn2041-1723
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1595
dc.identifier.eissn2041-1723
dc.identifier.doi10.1038/s41467-018-03512-5
dc.description.abstractNeural crest migration is critical to its physiological function. Mechanisms controlling mammalian neural crest migration are comparatively unknown, due to difficulties accessing this cell population in vivo. Here we report requirements of glycogen synthase kinase 3 (GSK3) in regulating the neural crest in Xenopus and mouse models. We demonstrate that GSK3 is tyrosine phosphorylated (pY) in mouse neural crest cells and that loss of GSK3 leads to increased pFAK and misregulation of Rac1 and lamellipodin, key regulators of cell migration. Genetic reduction of GSK3 results in failure of migration. We find that pY-GSK3 phosphorylation depends on anaplastic lymphoma kinase (ALK), a protein associated with neuroblastoma. Consistent with this, neuroblastoma cells with increased ALK activity express high levels of pY-GSK3, and blockade of GSK3 or ALK can affect migration of these cells. Altogether, this work identifies a role for GSK3 in cell migration during neural crest development and cancer.
dc.formatElectronic
dc.format.extent1126 - ?
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCell Line, Tumor
dc.subjectNeural Crest
dc.subjectAnimals
dc.subjectMice, Knockout
dc.subjectXenopus laevis
dc.subjectHumans
dc.subjectMice
dc.subjectNeuroblastoma
dc.subjectGlycogen Synthase Kinase 3
dc.subjectXenopus Proteins
dc.subjectCell Movement
dc.subjectPhosphorylation
dc.subjectCell Lineage
dc.subjectPregnancy
dc.subjectFemale
dc.subjectGlycogen Synthase Kinase 3 beta
dc.subjectAnaplastic Lymphoma Kinase
dc.titleGlycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus.
dc.typeJournal Article
dcterms.dateAccepted2018-02-20
rioxxterms.versionofrecord10.1038/s41467-018-03512-5
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-03-19
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNature communications
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Paediatric Solid Tumour Biology and Therapeutics
pubs.publication-statusPublished
pubs.volume9
pubs.embargo.termsNot known
icr.researchteamPaediatric Solid Tumour Biology and Therapeutics
dc.contributor.icrauthorPoon, Evon
dc.contributor.icrauthorChesler, Louis


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0